BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1570489)

  • 1. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.
    Scheja A; Akesson A; Hørslev-Petersen K
    Scand J Rheumatol; 1992; 21(1):5-9. PubMed ID: 1570489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
    Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
    Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxyterminal type I procollagen peptide concentrations in systemic sclerosis: higher levels in early diffuse disease.
    Scheja A; Hellmer G; Wollheim FA; Akesson A
    Br J Rheumatol; 1993 Jan; 32(1):59-62. PubMed ID: 8422562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
    Heickendorff L; Parvez A; Bjerring P; Halkier-Sørensen L; Zachariae H
    Acta Derm Venereol; 1991; 71(3):185-8. PubMed ID: 1678217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of type I and III collagen and hyaluronan in scleroderma skin.
    Søndergaard K; Heickendorff L; Risteli L; Risteli J; Zachariae H; Stengaard-Pedersen K; Deleuran B
    Br J Dermatol; 1997 Jan; 136(1):47-53. PubMed ID: 9039294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
    Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
    Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid.
    Faber J; Hørslev-Petersen K; Perrild H; Lorenzen I
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1016-21. PubMed ID: 2401705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of serologic markers for collagen synthesis and degradation in systemic sclerosis.
    Heickendorff L; Zachariae H; Bjerring P; Halkier-Sørensen L; Søndergaard K
    J Am Acad Dermatol; 1995 Apr; 32(4):584-8. PubMed ID: 7896946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
    Zachariae H; Halkier-Sørensen L; Heickendorff L
    Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoterminal propeptide of type III procollagen and hyaluronan in patients with primary biliary cirrhosis: markers of fibrosis in primary biliary cirrhosis.
    Remmel T; Remmel H; Salupere V
    J Gastroenterol Hepatol; 1996 Nov; 11(11):1016-20. PubMed ID: 8985819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: relation to clinical symptoms, liver histopathology and outcome.
    Nyberg A; Lindqvist U; Engström-Laurent A
    J Intern Med; 1992 May; 231(5):485-91. PubMed ID: 1602286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum levels of laminin, type IV collagen, procollagen III N-terminal peptide, and hyaluronic acid with the progression of interstitial lung disease.
    Su Y; Gu H; Weng D; Zhou Y; Li Q; Zhang F; Zhang Y; Shen L; Hu Y; Li H
    Medicine (Baltimore); 2017 May; 96(18):e6617. PubMed ID: 28471958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma endothelin and the aminoterminal propeptide of type III procollagen (PIIINP) in systemic sclerosis.
    Zachariae H; Heickendorff L; Bjerring P; Halkier-Sørensen L; Søndergaard K
    Acta Derm Venereol; 1994 Sep; 74(5):368-70. PubMed ID: 7817674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic and renal extraction of circulating type III procollagen amino-terminal propeptide and hyaluronan in pig.
    Bentsen KD; Henriksen JH; Boesby S; Hørslev-Petersen K; Lorenzen I
    J Hepatol; 1989 Sep; 9(2):177-83. PubMed ID: 2809157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites.
    Hørslev-Petersen K; Ammitzbøll T; Engström-Laurent A; Bentsen K; Junker P; Asboe-Hansen G; Lorenzen I
    J Rheumatol; 1988 Mar; 15(3):460-7. PubMed ID: 3259985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid from patients with pulmonary fibrosis.
    Milman N; Kristensen MS; Bentsen K
    APMIS; 1995 Oct; 103(10):749-54. PubMed ID: 8534435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin scoring in systemic sclerosis: a modification--relations to subtypes and the aminoterminal propeptide of type III procollagen (PIIINP).
    Zachariae H; Bjerring P; Halkier-Sørensen L; Heickendorff L; Søndergaard K
    Acta Derm Venereol; 1994 Nov; 74(6):444-6. PubMed ID: 7701875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement.
    Scheja A; Wildt M; Wollheim FA; Akesson A; Saxne T
    Rheumatology (Oxford); 2000 Oct; 39(10):1110-3. PubMed ID: 11035131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
    Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
    Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of amino terminal propeptide of type III procollagen are an unfavourable predictor of survival in systemic sclerosis.
    Nagy Z; Czirják L
    Clin Exp Rheumatol; 2005; 23(2):165-72. PubMed ID: 15895885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.